Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Response to "Treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71).

Wanigasekera V, Wartolowska K, Huggins JP, Duff EP, Vennart W, Whitlock M, Massat N, Pauer L, Rogers P, Hoggart B, Tracey I.

Br J Anaesth. 2019 Aug;123(2):e166-e171. doi: 10.1016/j.bja.2019.01.016. Epub 2019 Apr 9. No abstract available.

2.

An evidence-based review of pregabalin for the treatment of fibromyalgia.

Arnold LM, Choy E, Clauw DJ, Oka H, Whalen E, Semel D, Pauer L, Knapp L.

Curr Med Res Opin. 2018 Aug;34(8):1397-1409. doi: 10.1080/03007995.2018.1450743. Epub 2018 Apr 16.

PMID:
29519159
3.

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging.

Wanigasekera V, Wartolowska K, Huggins JP, Duff EP, Vennart W, Whitlock M, Massat N, Pauer L, Rogers P, Hoggart B, Tracey I.

Br J Anaesth. 2018 Feb;120(2):299-307. doi: 10.1016/j.bja.2017.11.064. Epub 2017 Nov 21.

4.

Normalizing fibromyalgia as a chronic illness.

Clauw DJ, D'Arcy Y, Gebke K, Semel D, Pauer L, Jones KD.

Postgrad Med. 2018 Jan;130(1):9-18. doi: 10.1080/00325481.2018.1411743. Epub 2017 Dec 19. Review.

PMID:
29256764
5.

Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.

Arnold LM, McCarberg BH, Clair AG, Whalen E, Thomas N, Jorga A, Pauer L, Vissing R, Park PW.

Postgrad Med. 2017 Nov;129(8):921-933. doi: 10.1080/00325481.2017.1384691. Epub 2017 Oct 16.

PMID:
28967801
6.

Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial.

Mu Y, Liu X, Li Q, Chen K, Liu Y, Lv X, Xu X, Fan D, Shang N, Yang R, Pauer L, Pan C.

J Diabetes. 2018 Mar;10(3):256-265. doi: 10.1111/1753-0407.12585. Epub 2017 Nov 1.

PMID:
28727270
7.

Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression.

Silverman SL, Backonja M, Pauer L, Landen J, Bhadra Brown P, Scavone JM, Vissing R, Clair A.

Pain Med. 2018 Mar 1;19(3):419-428. doi: 10.1093/pm/pnx091.

PMID:
28525632
8.

Corrections to: Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.

Arnold LM, Arsenault P, Huffman C, Patrick J, Messig M, Chew M, Sanin L, Scavone J, Pauer L, Clair A.

Curr Med Res Opin. 2017 Apr;33(4):795-796. doi: 10.1080/03007995.2017.1292446. Epub 2017 Feb 10. No abstract available.

PMID:
28276874
9.

Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.

Arnold LM, Schikler KN, Bateman L, Khan T, Pauer L, Bhadra-Brown P, Clair A, Chew ML, Scavone J; Pregabalin Adolescent Fibromyalgia Study Group.

Pediatr Rheumatol Online J. 2016 Jul 30;14(1):46. doi: 10.1186/s12969-016-0106-4.

10.

Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis.

Argoff CE, Emir B, Whalen E, Ortiz M, Pauer L, Clair A.

Pain Med. 2016 Nov;17(11):2100-2108. Epub 2016 Jun 1.

PMID:
27257288
11.

Burden of illness in fibromyalgia patients with comorbid depression.

Bateman L, Sarzi-Puttini P, Burbridge CL, Landen JW, Masters ET, Bhadra Brown P, Scavone JM, Emir B, Vissing RS, Clair AG, Pauer LR.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S106-13. Epub 2016 Mar 10.

PMID:
27057659
12.

The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women.

Lockwood PA, Pauer L, Scavone JM, Allard M, Mendes da Costa L, Alebic-Kolbah T, Plotka A, Alvey CW, Chew ML.

J Hum Lact. 2016 Aug 1;32(3):NP1-NP8. Epub 2016 Mar 9.

PMID:
26961752
13.

Association of Alterations in Gray Matter Volume With Reduced Evoked-Pain Connectivity Following Short-Term Administration of Pregabalin in Patients With Fibromyalgia.

Puiu T, Kairys AE, Pauer L, Schmidt-Wilcke T, Ichesco E, Hampson JP, Napadow V, Clauw DJ, Harris RE.

Arthritis Rheumatol. 2016 Jun;68(6):1511-21. doi: 10.1002/art.39600.

14.

Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.

Arnold LM, Sarzi-Puttini P, Arsenault P, Khan T, Bhadra Brown P, Clair A, Scavone JM, Driscoll J, Landen J, Pauer L.

J Rheumatol. 2015 Jul;42(7):1237-44. doi: 10.3899/jrheum.141196. Epub 2015 Jun 1.

PMID:
26034150
15.

Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study.

Raskin P, Huffman C, Yurkewicz L, Pauer L, Scavone JM, Yang R, Parsons B.

Clin J Pain. 2016 Mar;32(3):203-10. doi: 10.1097/AJP.0000000000000254.

PMID:
25968451
16.

Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia.

Argoff CE, Clair A, Emir B, Whalen E, Ortiz M, Pauer L.

Clin J Pain. 2016 Jul;32(7):555-61. doi: 10.1097/AJP.0000000000000232.

PMID:
25756560
17.

Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.

Huffman C, Stacey BR, Tuchman M, Burbridge C, Li C, Parsons B, Pauer L, Scavone JM, Behar R, Yurkewicz L.

Clin J Pain. 2015 Nov;31(11):946-58. doi: 10.1097/AJP.0000000000000198.

PMID:
25565583
18.

Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia.

Arnold LM, Emir B, Pauer L, Resnick M, Clair A.

Pain Med. 2015 Jan;16(1):176-85. doi: 10.1111/pme.12636. Epub 2014 Dec 19.

PMID:
25529830
19.

Challenges In Meeting Evidence Needs Of Payer, Physician, Patient And Industry Stakeholders For Novel Therapeutics.

Pauer L.

Value Health. 2014 Nov;17(7):A586-7. doi: 10.1016/j.jval.2014.08.2000. Epub 2014 Oct 26. No abstract available.

20.

Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.

Arnold LM, Arsenault P, Huffman C, Patrick JL, Messig M, Chew ML, Sanin L, Scavone JM, Pauer L, Clair AG.

Curr Med Res Opin. 2014 Oct;30(10):2069-83. doi: 10.1185/03007995.2014.928275. Epub 2014 Jun 27. Erratum in: Curr Med Res Opin. 2017 Apr;33(4):795-796.

PMID:
24867298
21.

Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients.

Harris RE, Napadow V, Huggins JP, Pauer L, Kim J, Hampson J, Sundgren PC, Foerster B, Petrou M, Schmidt-Wilcke T, Clauw DJ.

Anesthesiology. 2013 Dec;119(6):1453-64. doi: 10.1097/ALN.0000000000000017.

PMID:
24343290
22.

Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.

Raskin P, Huffman C, Toth C, Asmus MJ, Messig M, Sanchez RJ, Pauer L.

Clin J Pain. 2014 May;30(5):379-90. doi: 10.1097/AJP.0b013e31829ea1a1.

PMID:
23887339
23.

Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.

Pauer L, Atkinson G, Murphy TK, Petersel D, Zeiher B.

Clin J Pain. 2012 Sep;28(7):609-14. doi: 10.1097/AJP.0b013e31823dd315.

PMID:
22688598
24.

Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.

Arnold LM, Emir B, Murphy TK, Zeiher BG, Pauer L, Scott G, Petersel D.

Clin Ther. 2012 May;34(5):1092-102. doi: 10.1016/j.clinthera.2012.03.003. Epub 2012 Apr 14.

PMID:
22503162
25.

Meeting the obligation to communicate clinical trial results to study volunteers.

Getz K, Hallinan Z, Simmons D, Brickman MJ, Jumadilova Z, Pauer L, Wilenzick M, Morrison B.

Expert Rev Clin Pharmacol. 2012 Mar;5(2):149-56. doi: 10.1586/ecp.12.7.

PMID:
22390557
26.

An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.

Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B; A0081100 Investigators.

J Rheumatol. 2011 Dec;38(12):2643-52. doi: 10.3899/jrheum.110569. Epub 2011 Oct 1.

PMID:
21965636
27.

Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change.

Byon W, Ouellet D, Chew M, Ito K, Burger P, Pauer L, Zeiher B, Corrigan B.

J Clin Pharmacol. 2010 Jul;50(7):803-15. doi: 10.1177/0091270009352187. Epub 2010 Mar 31.

PMID:
20357295
28.

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.

Montgomery S, Chatamra K, Pauer L, Whalen E, Baldinetti F.

Br J Psychiatry. 2008 Nov;193(5):389-94. doi: 10.1192/bjp.bp.107.037788.

PMID:
18978320
29.

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.

Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L.

BMC Neurol. 2008 Sep 16;8:33. doi: 10.1186/1471-2377-8-33.

30.

Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors.

Pauer LR, Olivares J, Cunningham C, Williams A, Grove W, Kraker A, Olson S, Nemunaitis J.

Cancer Invest. 2004;22(6):886-96.

PMID:
15641487

Supplemental Content

Support Center